🧿 Innovative Therapeutic Strategies for Age-Related Ocular Diseases

We are developing targeted treatment approaches for age-related ocular diseases such as age-related macular degeneration, diabetic retinopathy, and intraocular tumors. Our research integrates nanomedicine, biomaterials, and molecular therapeutics to address the unmet clinical needs in the aging population.

🧪 Development of Long-Acting Functional Nanoantioxidants

This project focuses on engineering functional nanoantioxidants capable of sustained activity in oxidative environments. These materials are designed to modulate redox imbalances in disease conditions and serve as next-generation therapeutics for degenerative ocular and neurological disorders.

💉 Injectable Hydrogel-Based Platforms for Gene and Cell Therapy

We are designing injectable hydrogel systems that enable localized and sustained delivery of therapeutic cells and genes. These biomaterial-based platforms are tailored for Gene/Cell therapy applications, offering biocompatibility, controlled release, and microenvironmental support for therapeutic efficacy.

💊 Precision Drug Delivery and Biopharmaceutical Design Using Lipid-Based Nanoparticles

This research aims to develop lipid-based nanocarriers for precise delivery of small molecules, nucleic acids, and biologics. By fine-tuning lipid composition and surface properties, we design advanced drug delivery systems that improve targeting, reduce side effects, and enhance therapeutic performance.

🧫 Engineering Stimuli-Responsive Nanocomposite Hydrogels for Advanced Tissue Regeneration

We are developing smart nanocomposite hydrogels that respond to physiological stimuli to control drug release and modulate cellular behavior. These systems are optimized for use in corneal and skin tissue regeneration, with potential applications across regenerative medicine.